A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2002

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Chronic Hepatitis B
Interventions
DRUG

Entecavir

Trial Locations (39)

10003

Local Investigator, New York

10029

Local Investigator, New York

10032

Local Investigator, New York

11030

Local Investigator, Manhasset

14642

Local Investigator, Rochester

15213

Local Investigator, Pittsburgh

19104

Local Investigator, Philadelphia

21205

Local Investigator, Dundalk

22031

Local Investigator, Fairfax

23249

Local Investigator, Richmond

27710

Local Investigator, Durham

28203

Local Investigator, Charlotte

30309

Local Investigator, Atlanta

30322

Local Investigator, Atlanta

33136

Local Investigator, Miami

33140

Local Investigator, Miami Beach

35294

Local Investigator, Birmingham

37211

Local Investigator, Nashville

44125

Local Investigator, Cleveland

48073

Local Investigator, Royal Oak

48109

Local Investigator, Ann Arbor

52242

Local Investigator, Iowa City

55114

Local Investigator, Saint Paul

60612

Local Investigator, Chicago

60622

Local Investigator, Chicago

70112

Local Investigator, New Orleans

75235

Local investigator, Dallas

85724

Local Investigator, Tucson

90048

Local Investigator, Los Angeles

90095

Local Investigator, Los Angeles

92037

Local Investigator, La Jolla

92115

Local Investigator, San Diego

92868

Local Investigator, Orange

94115

Local Investigator, San Francisco

96820

Local Investigator, Honolulu

06030

Local Investigator, Farmington

02111

Local Investigator, Boston

01655

Local Investigator, Worcester

02908

Local Investigator, Providence

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY